NEW YORK (GenomeWeb News) – Richard Rava has joined Artemis Health as senior VP of research and development, a new position at the firm. Rava comes to Artemis from Affymetrix, where he was a scientific co-founder and most recently senior vice president of research and development.
Joseph Blanchard will take over the CEO position at Aushon Biosystems. Blanchard previously was senior VP of business development and strategy at Decision Biomarkers, and he has spent over 20 years in the life sciences field, Aushon said this week.
Agendia has tapped Alan Carter to serve as its new VP of global business development. Carter formerly served as an executive at BioTrove, Celera, Applied Biosystems, and PerkinElmer. At Agendia, Carter will handle strategic business opportunities for the company's molecular diagnostics portfolio.
Axela has brought in BioMark CEO Butch Mercer to help the company pursue opportunities using the company's technology in the animal health, environmental testing, food safety, and plant agriculture markets.
The American Institute for Medical and Biological Engineering has inducted Gualberto Ruano to its College of Fellows. Ruano is president and CEO of Genomas, director of genetics research at Hartford Hospital, and an adjunct professor in the medical faculties at George Washington University and at the University of Puerto Rico.
Cellumen has promoted Kate Johnston to be chief scientific officer. Johnston started in 2005 as VP of discovery programs, and before that she spent ten years at Sphinx Pharmaceuticals, where she also worked as a senior scientist. She also is a member of the Spinal Muscular Atrophy Project.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.